Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05041335 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Wet Heparinized Suction for Abdominal Cancer

Study acronym: EUS Heparin
StatusWithdrawn
PhaseNot applicable
Started2025-11-25
View on ClinicalTrials.gov ↗

Amendment history

2026-09-18
critical
Withdrawn before enrolling
Trial withdrawn: study no longer proceeding
Primary completion confirmed: November 2025 (last estimated January 2027)
2025-04-21
minor
Study Status v13
Primary completion date2026-01-12→2027-01-12
Completion date2026-01-12→2027-01-12
Start date2025-03-15→2026-03-15
2025-01-14
minor
Study Status v12
Primary completion date2025-01-12→2026-01-12
Completion date2025-01-12→2026-01-12
Start date2024-12-15→2025-03-15
2024-10-22
minor
Study Status v11
Primary completion date2024-12-12→2025-01-12
Completion date2024-12-12→2025-01-12
Start date2024-09-15→2024-12-15
2024-08-28
minor
Study Status v10
Start date2024-08-15→2024-09-15
Show 9 earlier versions
2024-07-05
minor
Study Status v9
Start date2024-06-15→2024-08-15
2024-05-10
minor
Study Status v8
Start date2024-04-15→2024-06-15
2024-03-18
minor
Study Status v7
Start date2024-02-15→2024-04-15
2024-01-23
minor
Study Status v6
Start date2023-12-15→2024-02-15
2023-09-22
minor
Study Identification, Study Status v5
Re-verified, no change to tracked fields
2023-01-23
minor
Study Status v4
Primary completion date2023-12-12→2024-12-12
Completion date2023-12-12→2024-12-12
Start date2022-12-15→2023-12-15
2022-08-10
minor
Study Status v3
Primary completion date2023-02-12→2023-12-12
Completion date2023-02-12→2023-12-12
Start date2022-07-15→2022-12-15
2022-02-28
minor
Study Status v2
Start date2022-02-15→2022-07-15
2022-01-18
notable
Recruiting→Not Yet Recruiting Study Identification, Study Status, Sponsor/Collaborators, Contacts/Locations v1
Trial statusRecruiting→Not Yet Recruiting
Primary completion date2022-02-12→2023-02-12
Completion date2022-02-12→2023-02-12
Start date2021-02-15→2022-02-15
Lead sponsorUniversity Hospitals Cleveland Medical Center→H. Lee Moffitt Cancer Center and Research Institute
Study sites1 entry, revised
UniversityMoffitt HospitalsCancer Center
2021-09-07
minor
Original filing
The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis. You will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not. You will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.
Trial Details
NCT Number NCT05041335
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Conditions Cancer of Pancreas, Cancer of Stomach, Cancer of Esophagus, Cancer of Liver, Cancer
Start Date 2025-11-25
Primary Completion 2025-11-25 (estimated)
Study Completion 2025-11-25 (estimated)
Updated on ClinicalTrials.gov 2026-09-17